Indaptus Therapeutics, Inc.INDPNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank14
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P14
Within normal range
vs 5Y Ago
-1.4x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -7.33% |
| 2023 | 1.99% |
| 2022 | 64.93% |
| 2021 | 451.33% |
| 2020 | -87.30% |
| 2019 | 5.18% |
| 2018 | 63.78% |
| 2017 | 40.46% |
| 2016 | 11.01% |
| 2015 | 6.90% |